Thank you to our Foundational and Sustaining members
CHICAGO, IL – June 15, 2021 – NorthShore University HealthSystem (NorthShore) has joined physIQ’s NIH-funded DeCODe study to develop an AI-based COVID-19 digital biomarker. NorthShore will serve as an enrollment center and key partner in the Phase II validation stage of this study. “Continuing NorthShore University HealthSystem’s mission to be at the forefront of innovation, we are thrilled to partner with physIQ again,” said […]
CHICAGO, IL – May 25, 2021 – Digital health leader, physIQ Inc., recently announced that Intermountain Healthcare Utah, The University of Texas Health Science Center at Houston (UTHealth) and Rush University Medical Center have joined the NIH-funded DeCODe study to develop an AI-based COVID-19 digital biomarker. These institutions will serve as recruiting centers and key partners in the Phase II validation stage of this study. Realization […]
CHICAGO, IL – May 4, 2021 – PhysIQ Inc., Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), announced their collaboration to deploy physIQ’s platform to support a clinical trial to evaluate investigational products for early treatment and post-exposure prophylaxis of COVID-19. In this 18-month study, continuous monitoring with sophisticated […]
Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics Endeavour Vision Closes Endeavour Medtech Growth II LP at USD 375m to Invest in Transformative Healthcare Technologies Celcuity Licensing Deal with Pfizer Drives Stock Up 85% in One Week One Year Out From Series B, Senior Care […]
CHICAGO, IL – April 20, 2021 – physIQ, a leader in real-world biosensor data collection and digital biomarkers, today announced a new multi-year collaboration to license physIQ’s accelerateIQTM to Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The relationship allows Janssen to scale the use of biosensors, supporting initiatives across both R&D and commercial strategies. With […]
A visionary leader with a demonstrated ability to craft innovative strategies, build exceptional management teams and manage to results in a fast-changing business environment, Gary is the Chairman, CEO and Founder. Prior to physIQ, he was the founding CEO and Chairman of SmartSignal Corporation (now part of GE), a Chicago-based enterprise software firm, incubated by the University of […]
CHICAGO, IL – February 9, 2021 – physIQ, Inc. and the US Department of Veteran’s Affairs (VA) have advanced their collaboration to address heart failure care to an interventional trial phase. In this next phase, Veterans will be actively monitored so care can be administered in near real-time to avoid or lower the chance of re-hospitalization, allowing the […]
Flywheel Lands $15M in Series B Financing UnitedHealth Names Former Glaxo CEO Witty to Lead Company Minneapolis Biotechnology Firm Bio-Techne Saw Dividends on Growth HistoSonics Announces First Patient Treated in U.S. Clinical Study of Novel Sonic Beam Therapy for Liver Tumors PhysIQ Hires Scripps Research Translational Institute Doctor as Chief Medical Officer Tech Behind Pet […]
CHICAGO, IL – February 2, 2021 – Dr. Steve Steinhubl, a leader in reinventing medicine through the convergence of healthcare and technology and an expert in physiology, has joined physIQ as Chief Medical Officer. Dr. Steinhubl will help advance the adoption of physIQ’s artificial intelligence (AI)-based analytics for improved clinical outcomes and lower costs. “Over the last […]
CHICAGO, IL – January 28, 2021 – PhysIQ, Inc. will mark 2020 as a very important year-to-date for the leader in furthering acceptance and adoption of its digital medicine platform. Throughout the year, announcements of breakthrough studies and publications, important partnerships and collaborations, and an additional FDA clearance, were just a few of the notable accomplishments for this innovative […]